Pharmacological increases in circulating ketones fail to alleviate the hypertrophic cardiomyopathy present in the Tafazzin knockdown mouse model of Barth syndrome. - Shafaati T; Greenwell AA; Saed CT; Tabatabaei Dakhili SA; Chan JSF; Dong L; Stenlund MJ; Ferrari SR; Han R; Kruger J; Eaton F; Gopal K; et al. (Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2025)